Gunilla Petersson is a consultant specialising in inhaled drug delivery. Until May 2023, she was Science & Innovation Director, Inhaled Drug Delivery, at AstraZeneca, affiliated to the Innovation Strategies & Internal Liaison (IS&EL) segment.

Dr Petersson was at AstraZeneca for almost 30 years, holding different line management and scientific expert roles linking formulations and devices, mainly for inhaled drug product development, having worked in technology development and scouting, product development and registrations of new products, competitor landscape, CMC industry consortia boards and working teams (EPAG, IPAC-RS) for 10 years, drug project due diligences and scientific marketing of AstraZeneca products.

She holds a PhD in Analytical Chemistry from Lund University (Sweden).